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ABSTRACT
DNA methylation is a mechanism for long-term tran-
scriptional regulation and is required for normal
cellular differentiation. Failure to properly establish
or maintain DNA methylation patterns leads to cell
dysfunction and diseases such as cancer. Identifying
DNA methylation signatures in complex tissues can
be challenging owing to inaccurate cell enrichment
methods and low DNA yields. We have developed a
technique called laser capture microdissection-
reduced representation bisulfite sequencing (LCM-
RRBS) for the multiplexed interrogation of the DNA
methylation status of cytosine–guanine dinucleotide
islands and promoters. LCM-RRBS accurately and re-
producibly profiles genome-wide methylation of DNA
extracted from microdissected fresh frozen or
formalin-fixed paraffin-embedded tissue samples. To
demonstrate the utility of LCM-RRBS, we char-
acterized changes in DNA methylation associated
with gonadectomy-induced adrenocortical neoplasia
in the mouse. Compared with adjacent normal
tissue, the adrenocortical tumors showed reprodu-
cible gains and losses of DNA methylation at genes
involved in cell differentiation and organ development.
LCM-RRBS is a rapid, cost-effective, and sensitive
technique for analyzing DNA methylation in
heterogeneous tissues and will facilitate the investi-
gation of DNA methylation in cancer and organ
development.
INTRODUCTION
DNA methylation has long been recognized to play a role
in normal cellular differentiation and development.
Methylation most often occurs at the cytosine of a
cytosine–guanine dinucleotide (CpG) and acts to down-
regulate gene expression (1). Disruption of the DNA
methylation machinery can lead to imprinting disorders
(2), repeat-instability disease (3) and neurological defects
(4,5).
DNA methylation has been shown to play an important
role in cancer progression. Tumors often display a global
loss of methylation, or hypomethylation, at repetitive
elements, which is thought to destabilize the genome
through transposon-mediated rearrangements (6,7),
activate growth-promoting oncogenes (7) and cause de-
differentiation through the loss of imprinting (8). An
abnormal gain of methylation, or hypermethylation, at
gene regulatory elements also contributes to tumorigenesis
by silencing tumor suppressor genes involved in DNA
damage repair, cell cycle control and other processes (9).
This aberrant methylation may be due, at least in part, to
recurring mutations in genes that are involved in epigen-
etic regulation (10,11), such as DNA methyltransferases,
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which are commonly mutated in acute myeloid leukemia
(12), and chromatin remodelling enzymes, which are fre-
quently mutated in renal carcinomas and pancreatic
neuroendocrine tumors (13,14).
Accurate analysis of DNA methylation is complicated
by the heterogeneous nature of normal and diseased
tissues. Normal tissues contain cells at different stages of
differentiation/maturity. Tumors also consist of
histologically diverse cell types (15,16) and display
intratumor heterogeneity in gene expression (17),
genotype (18,19) and metastatic and proliferative potential
(20,21). Therefore, the analysis of gross tumor samples
often obscures the diverse cell types that comprise the
entire tumor (22). To assess cell type–speciﬁc DNA methy-
lation of complex tissues, cell isolation techniques must be
used. Laser capture microdissection (LCM) has enabled
researchers to separate speciﬁc cell types from heteroge-
neous tissues (23). DNA yields from such samples,
however, are too small to use with current methods for
genome-wide DNA methylation analysis. Moreover,
clinical samples are typically ﬁxed in formalin and
embedded in parafﬁn, further compromising DNA
quality. For these reasons, the genome-wide mapping of
DNA methylation in LCM samples has not been previ-
ously demonstrated.
Current DNA methylation analysis methods are limited
by the number of loci interrogated, quantity and quality of
DNA input required, and sample throughput (24).
Methods that function on a very small number of cells
interrogate only a few genomic loci and are challenging
to implement (25,26). Furthermore, few methods function
on clinical samples that are formalin-ﬁxed and parafﬁn-
embedded (FFPE) (26). Genome-wide DNA methylation
methods are limited by the input of DNA. Afﬁnity enrich-
ment techniques like MeDIP-Seq (27), MDB-seq (28) and
MethylCap-seq (29) require 0.16–5 mg of DNA input and
are limited to a 150- to 200-bp resolution. Other global
methods, like CHARM (30) and padlock probes (31,32),
also require large DNA inputs. MethylC-seq, the only
truly whole-genome approach (33), is prohibitively expen-
sive when many samples need to be analyzed. Reduced
representation bisulﬁte sequencing (RRBS) can map
genome-wide DNA methylation of limited DNA samples
(34), but has not been demonstrated to function on small
amounts of DNA recovered from FFPE samples or on
samples collected by LCM.
Here, we describe a new technique termed laser capture
microdissection-reduced representation bisulﬁte seq-
uencing (LCM-RRBS) that can interrogate genome-wide
DNA methylation patterns in samples collected from
complex heterogeneous tissues. As a proof of principle,
we have used LCM-RRBS to analyze global DNA methy-
lation changes associated with adrenocortical neoplasia in
the mouse. In response to gonadectomy (GDX) and the
ensuing rise in serum gonadotropin levels, sex steroid–
producing neoplasms accumulate in the subcapsular
region of the adrenal cortex of certain strains of mice,
including DBA/2J (35). This phenomenon is thought to
reﬂect gonadotropin-induced metaplasia of stem/progeni-
tor cells in the adrenal cortex, although the term ‘neopla-
sia’ is used more often than ‘metaplasia’ to describe the
process (35). The molecular basis of GDX-induced
adrenocortical neoplasia is unknown (36,37), but it has
been hypothesized that DNA methylation and other epi-
genetic modiﬁcations may impact the phenotypic plasti-
city of adrenocortical stem/progenitor cells, allowing
them to respond to the rise in circulating gonadotropins
(38). GDX-induced adrenocortical neoplasia in the mouse
is an ideal phenomenon to study using LCM-RRBS
because of the limited amounts of tissue that can be
collected.
MATERIALS AND METHODS
Experimental mice
Procedures involving mice were approved by an institu-
tional committee for laboratory animal care and were con-
ducted in accordance with NIH guidelines for the care and
use of experimental animals. C57BL/6J and DBA/2J mice
were purchased from Jackson Laboratories (Bar Harbor,
ME). Mice were anesthetized and ovariectomized at 3–4
weeks of age (39).
DNA extraction
Human tumor specimens were collected under an
institutional review board–approved protocol. Immedi-
ately after surgery, a human endometrial tumor was
divided in half. One half was fresh frozen, whereas the
other was formalin ﬁxed and parafﬁn embedded (FFPE).
Fifty milligrams of fresh frozen endometrial tumor was
cut into small pieces with a sterile scalpel blade, and
DNA extracted using the Maxwell 16 Tissue DNA
Puriﬁcation Kit (AS1030, Promega). The FFPE preserved
portion was cut into 6-mm sections onto microscope slides.
Four 4-mm2 slices were scratched off the slide with a
sterile scalpel blade and combined in 80 ml of buffer and
proteinase K (740901.50, Clontech) and incubated over-
night at 65C. Liver tissue was harvested from C57BL/6J
mice and divided in half. One half was preserved in Tissue-
tek optimal cutting temperature (O.C.T.) compound
(25608-930, VWR) and snap frozen, whereas the other
half was FFPE for downstream bulk DNA extraction
and LCM. Fresh frozen, FFPE and LCM samples were
puriﬁed using NucleoSpin Tissue XS columns (740901.5,
Clontech) following the protocol for laser-microdissected
tissue and eluted in 20 ml of nuclease-free water. Genomic
DNA was quantiﬁed using the Quant-it dsDNA High-
Sensitivity kit (Invitrogen) and the Qubit ﬂuorometer
(Invitrogen).
Laser capture microdissection
Adrenal glands were harvested from mice 3 months after
ovariectomy. Liver and adrenal cryosections (10 mm) were
collected on membrane slides (PEN-Membrane 2.0 mm;
Leica) designed to free the dissectate from the remainder
of the tissue section. Adrenal tissue sections were ﬁxed in
acetone (5 s, 20C), stained with hematoxylin and eosin
(H&E) or crystal violet and dehydrated by passage
through successively higher concentrations of ethanol
followed by xylene. FFPE liver sections were
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deparafﬁnized and dehydrated using standard methods.
LCM was performed using a Leica LMD6000 microscope.
Dissectates were collected in SDS/proteinase K for
genomic DNA isolation (740901.5, Clontech).
RRBS and LCM-RRBS
RRBS was performed on 400 ng of commercially
purchased leukocyte genomic DNA (D1234148, Amsbio)
and genomic DNA extracted from a mouse liver as previ-
ously described (40). For LCM-RRBS, leukocyte genomic
DNA (1 ng), extracted endometrial tumor genomic DNA
(1 ng) and LCM DNA samples were incubated overnight
at 37C with 20U of the methylation-insensitive restric-
tion enzyme MspI (R0106S, NEB) and 2 ml of 10
NEBuffer 2 in an 18-ml reaction. Without subsequent puri-
ﬁcation, fragment ends were ﬁlled in, and an adenosine
added with 10U of Klenow Fragment (30 ! 50 exo,
M0212L, NEB), 0.04mM dGTP, 0.04mM dCTP,
0.4mM dATP and 1 NEBuffer 2 to a ﬁnal volume of
22.4 ml. The reaction was incubated at 30C for 20 min,
37C for 20min, and 75C for 20min. Pre-annealed
methylated paired-end Illumina indexing adapters
(Adap1: ACACTCTTTCCCTACACGACGCTCTTCC
GATCT; Adap2: P-GATCGGAAGAGCACACGTCTG
AACTCCAGTCAC, P=phosphate) at a concentration
of 0.26mM were ligated overnight at 16C to the ends
of the DNA fragments using 1200U of T4 DNA Ligase
(M0202L, NEB) in 1 Ligase Buffer to a ﬁnal volume of
28.9 ml. These adapter oligonucleotides are only comple-
mentary at 13 bases, which, after annealing, form a ‘Y’
structure. Because excess adapters prevent the complete
conversion of CpGs at the MspI digestion site, adapter-
ligated fragments are puriﬁed using MinElute columns
(Qiagen) and eluted twice with 11 ml of warm EB buffer
(Qiagen). The puriﬁed products were treated using the EZ
DNA Methylation Gold Kit (D5005, Zymo). Samples
were eluted in 11 ml of M-Elution buffer. To incorporate
the sample-speciﬁc index, 3 ml of each bisulﬁte-treated
sample was ampliﬁed in triplicate with 0.2 mM of
indexed primers (PCR1: AATGATACGGCGACCACC
GAGATCTACACTCTTTCCCTACACGACGCTCTTC
CGATCT; PCR2: CAAGCAGAAGACGGCATACGA
GATNNNNNGTGACTGGAGTTCAGACGTGTGCT
CTTCCGA, N= index), 5 U of Platinum Taq Polymerase
(10966-034, Invitrogen), 1 PCR buffer, 2mM MgCl2,
0.5M betaine (B0300, Sigma) and 1mM dNTP, in a
10-ml reaction using the following cycling conditions:
98C for 2min, 12 cycles of 98C for 30 s and 65C for
2min. All PCR products and replicates were pooled and
analyzed by electrophoresis on a 3% 1 Tris-acetate-
EDTA NuSieve agarose gel (50090, Lonza) using a
voltage of 5V/cm until the blue loading dye was 6–7 cm
away from the loading well. Fragments between 150 and
350 bp were extracted and puriﬁed using MinElute
columns (Qiagen) and 15 ml of warmed EB buffer.
Before ﬁnal library PCR enrichment, the minimum cycle
number must be determined to ensure no PCR bias.
Using 2 ml of eluted product and 0.2 mM universal
primers (Pool1: CAAGCAGAAGACGGCATACGAG
AT, Pool2: AATGATACGGCGACCACCGAGATCT),
multiple PCR reactions with a ﬁnal volume of 50 ml are
set up using the previous conditions but varying the cycle
number from 10 to 16 cycles. Ten microliters of each PCR
product is analyzed through electrophoresis on a 4–20%
Precast Tris-borate-EDTA (TBE) gel (3450059, BioRad)
and stained with Sybr Gold (S-11494, Invitrogen) for
15min and imaged. To minimize PCR bias, the ﬁnal
PCR library is ampliﬁed in quadruplicate using the
previous PCR conditions and the minimum cycle
number (typically 14) that shows ampliﬁcation only
within the 150- to 350-bp range on the Sybr Gold–
stained TBE gel. The four replicates are pooled and gel
extracted as previously mentioned to remove remaining
adapter dimers and primers, puriﬁed and sequenced on
Illumina HiSeq 2000 machines.
Bisulﬁte-speciﬁc PCR
Neoplastic and adjacent normal mouse adrenocortical
tissue was collected and bisulﬁte treated using the EZ
DNA Methylation-Direct kit following the manufac-
turer’s instructions for LCM samples eluting with 15 ml
of nuclease-free water (D5020, Zymo). Bisulﬁte-speciﬁc
PCR (BSP) primers were designed using MethPrimer
(http://www.urogene.org/methprimer/). To amplify the
promoter regions of interest, 2 ml of bisulﬁte-treated
DNA was combined with 2.5U of Jumpstart Taq
(Sigma), 1 PCR buffer, 1M betaine (B0300, Sigma),
0.2mM dNTP and 0.4 mM of each primer in a total
reaction volume of 25 ml. The reaction was incubated at
95C for 5min, followed by 5 cycles at 94C for 30 s, 60C
for 30 s and 72C for 90 s, followed by 5 cycles at 94C for
30 s, 55C for 30 s and 72C for 90 s, followed by 30–33
cycles at 94C for 30 s, 50C for 30 s and 72C for 90 s,
followed by incubation at 72C for 5min. PCR products
were prepared for sequencing on the MiSeq following the
manufacturer’s protocol (Illumina).
Sequence alignment and methylation calling
All analysis was performed using the February 2009
(GrCh37/hg19) build of the human genome and the July
2007 (NCBI37/mm9) build of the mouse genome. On
average, 25 million single-end 42-bp raw high-quality
reads per sample were either aligned to the cytosine-
poor strand reference using the bisulﬁte mode of MAQ
(41) or aligned to the reduced reference using
RRBSMAP (42) ﬁltering against reads that contain
adapter sequence. Reads that showed <90% bisulﬁte con-
version (approximately one unconverted non-CpG
cytosine per read) were ﬁltered to remove those that
resulted from incomplete bisulﬁte-converted molecules.
Aligned reads with a mapping quality of zero were also
discarded. The resulting high-quality uniquely mapped
reads were used for methylation calling. We identiﬁed
the genomic coordinates of all CpGs in the reference
sequence and assessed percent DNA methylation by
calculating the fraction of reads that had an unconverted
cytosine at the CpG position relative to the total reads.
We required that each read have either a ‘TG’ or ‘CG’
dinucleotide at the expected CpG coordinate to be con-
sidered for analysis.
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Genomic feature annotation and statistical analysis
Cytosine methylation levels were determined for two
classes of genomic features downloaded from the UCSC
genome browser (43). CpG islands (CGIs) were deﬁned as
a region >200 bp with a GC content of 50% or greater
and observed-to-expected ratio of CG dinucleotides >0.6
(44). Promoters were deﬁned as a 2-kb region centered on
the annotated transcription start site (TSS) of RefSeq
genes (45). For LCM-RRBS, RRBS, fresh frozen and
FFPE comparisons, only genomic features with at least
50 methylation measurements in each pairwise compari-
son were considered for analysis.
To identify differentially methylated promoters in
adrenocortical neoplasia and normal samples, the DNA
methylation status of all CpGs within a 2-kb region of all
RefSeq annotated TSSs were compared. Those promoters
with at least 50 methylation measurements that showed
>10% methylation difference were considered for statis-
tical analysis. Promoters were considered statistically sig-
niﬁcant with a P< 0.05 using Student’s t-test after
P-values were adjusted using a false-discovery rate
(FDR) of 5%. Statistical signiﬁcance across BSP
samples was determined using the Fisher’s exact test. All
statistical analysis was performed using R.
Data release
The DNA methylation data generated for this study can be
found under the NCBI Gene Expression Omnibus (GEO)
accession number GSE 45361. DNA methylation and raw
sequence data are also publically available at the Center for
Genome Sciences (www.cgs.wustl.edu/maxim/).
RESULTS
LCM-RRBS
RRBS is an established methylation analysis method that
can interrogate most CGIs and promoters across the
entire genome. Current RRBS protocols, however, do
not allow for multiplexing and have not been
demonstrated on samples isolated by LCM.
Furthermore, although RRBS has been used to analyze
small amounts of high-quality DNA (34), it has not been
applied to <1 mg of DNA extracted from FFPE samples
(46), the most common method used to preserve clinical
tissue samples. We therefore sought to develop a method
to analyze small amounts (1 ng) of DNA from laser
capture microdissected samples and from FFPE-preserved
samples, and to interrogate multiple samples in parallel.
Our protocol removes most clean-up steps, which
ensures DNA samples are not lost, and leverages the
capabilities of Illumina indexing to pool samples before
size selection and sequencing, thus dramatically increasing
the number of samples that can be processed in parallel
(Figure 1). LCM-RRBS digests genomic DNA with MspI
to create fragments with a 50-CpG end. Digested frag-
ments are blunted, adenylated and ligated with methylated
sequencing adapters and then column puriﬁed to remove
excess adapters. To convert the epigenetic methylation
mark into a genetic mark that can be read through
genomic sequencing, adapter-ligated fragments are
treated with bisulﬁte. At this stage, converted DNA is
ampliﬁed with a low-cycle PCR to introduce sample-
speciﬁc indexes. Once each sample is ‘indexed’, samples
are pooled before gel electrophoreses and the isolation
of 40- to 220-bp fragments. The puriﬁed pooled library
is PCR enriched using universal primers and sequenced
on the Illumina platform to generate 42-bp reads. Using
our modiﬁed method, we can interrogate CpGs genome-
wide from laser capture microdissected samples freshly
frozen or previously preserved through formalin ﬁxing
and parafﬁn embedding.
LCM-RRBS accurately measures genome-wide DNA
methylation of fresh frozen and FFPE samples
To evaluate the performance of LCM-RRBS, we bench-
marked it against RRBS. Using 1 and 400 ng for
LCM-RRBS and RRBS, respectively, we compared the
genome-wide DNA methylation status of DNA isolated
from human blood leukocytes. We did not do LCM on the
1 ng of puriﬁed DNA; instead, we only applied the down-
stream library preparation of the LCM-RRBS protocol
(Figure 1). LCM-RRBS was able to interrogate >75%
of CGIs and >65% of gene promoters, results that were
similar to those obtained by RRBS (Supplementary
Figure S1). LCM-RRBS was able to accurately measure
the DNA methylation levels of CGIs and core promoters
(Figure 2A) as well as individual CpG dinucleotides
(Supplementary Figure S2). Increasing the required
coverage for each CpG considered for CGI methylation
did not signiﬁcantly alter the concordance between RRBS
and LCM-RRBS (Supplementary Figure S3). For CGIs
(n=18448) and promoters (n=8500) having at least 50
methylation measurements, we observed a Pearson correl-
ation of 0.98 and 0.94, respectively, between 1 and 400 ng
(Figure 2A). Most CGIs are either highly methylated
(80–100%) or highly unmethylated (0–20%). We therefore
sought to test how well LCM-RRBS could call a CGI as
methylated or unmethylated. For CGIs with at least 50
high-quality CpG measurements, LCM-RRBS identiﬁed
methylated CGIs with 91% sensitivity and 99% speciﬁcity
and unmethylated CGIs with 97% sensitivity and 94%
speciﬁcity when compared with the RRBS dataset. We
therefore conclude that LCM-RRBS functions on as
little as 1 ng of genomic DNA, interrogates most CGIs
and promoters and is very accurate.
Human clinical samples are usually stored as either
fresh frozen or FFPE specimens. Mapping DNA methy-
lation in the latter, however, can be challenging because
formalin ﬁxation degrades DNA. Most DNA methylation
techniques that have been used on FFPE samples require
>1 mg of DNA or can only interrogate a few loci. To
validate the reproducibility of LCM-RRBS and demon-
strate its universal clinical applicability, we performed
methylation proﬁling on 1-ng samples of DNA from a
primary endometrial carcinoma, half of which was fresh
frozen and the remainder which was FFPE preserved.
Methylation of CGIs and promoters was highly concord-
ant between fresh frozen and FFPE samples (Pearson cor-
relation 0.98 and 0.97, respectively; Figure 2B). CGI and
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promoter methylation correlated strongly between FFPE
technical replicates (Pearson correlation 0.97 and 0.95, re-
spectively; Supplementary Figure S4). We also observed
high concordance across individual CpGs between fresh
frozen and FFPE tumor samples, with a Pearson correl-
ation of 0.96 (Supplementary Figure S2). LCM-RRBS,
therefore, can accurately interrogate genome-wide methy-
lation of 1 ng extracted from FFPE samples.
LCM-RRBS is robust across fresh frozen and FFPE laser
capture microdissected samples
In situ analysis of DNA methylation is challenging owing
to the heterogeneous nature of complex tissues. To
interrogate only cells of interest in biological and clinical
samples, LCM techniques must be used to enrich for a
speciﬁc cell type. Current genome-wide DNA methylation
methods, however, have not been demonstrated to
function on LCM-collected samples. We therefore set
out to evaluate the performance of LCM-RRBS on fresh
frozen and FFPE samples collected by LCM.
Because the cellular architecture of a normal liver is
homogeneous, the methylation state should be very
similar throughout the organ. Thus, the liver serves as
the ideal tissue for benchmarking the LCM-RRBS
method against the RRBS gold standard, as each
microdissected region should have a very similar
Figure 1. LCM-RRBS workﬂow. A complex tissue is dissected using LCM. Extracted DNA is digested by the methylation-insensitive enzyme MspI,
end repaired and ligated with methylated Illumina adapters. After bisulﬁte conversion, each sample is ‘barcoded’ by introducing a sample-speciﬁc
index (shown as green, blue or violet boxes) through low-cycle PCR. Samples are pooled and loaded onto a high-percentage gel for fragment
separation and size selection. Using universal primers, the ﬁnal library is ampliﬁed and sequenced on the Illumina platform.
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methylation pattern to that of the bulk tissue. We har-
vested the liver of C57BL/6J mice and prepared the liver
using standard preservation techniques. Separate regions
of the liver were either directly snap frozen, preserved in
Tissue-Tek O.C.T. compound and then snap frozen or
preserved using formalin ﬁxation and parafﬁn embedding.
Bulk DNA was extracted from the snap-frozen sample
and used for downstream RRBS analysis. To determine
whether the process of LCM alters the methylation of
DNA and to assess the lower limits of LCM-RRBS, we
applied LCM-RRBS to samples collected from 20, 10, 5
and 2mm2 of the fresh frozen and FFPE mouse liver and
compared the DNA methylation patterns with those
determined by performing RRBS on 400 ng of DNA ex-
tracted from the bulk fresh frozen liver tissue. As observed
with 1 ng of DNA, most CGIs and promoters were repre-
sented even when only 2mm2 of tissue was collected
(Supplementary Figure S5). Furthermore, CGI (mean
Pearson=0.98) and promoter (mean Pearson=0.96)
methylation showed high concordance across all
fresh frozen samples (Figure 3A) when compared
with 400 ng of DNA. For samples collected from 2mm2
of microdissected tissue, LCM-RRBS identiﬁed
unmethylated (0–20%) CGIs with 88% sensitivity and
99% speciﬁcity and methylated (80–100%) CGIs with
99% sensitivity and 87% speciﬁcity. While the interroga-
tion of DNA methylation of 2 mm2 of fresh frozen tissue
was robust, 20 mm2 of FFPE tissue was required for
accurate analysis. Using 20 mm2 of FFPE starting
material, LCM-RRBS showed 79% sensitivity and 99%
speciﬁcity for calling unmethylated (0–20%) CGIs and
99% sensitivity and 78% speciﬁcity for calling methylated
(80–100%) CGIs, with a Pearson correlation of 0.95
(Figure 3B). Samples collected from <20mm2 of FFPE
tissue, however, showed poor CGI, promoter and CpG
correlations as compared with 400 ng (data not shown).
We conclude that the process of LCM does not alter DNA
methylation, and that LCM-RRBS accurately determines
methylation patterns from as little as 2mm2 of fresh
frozen tissue. FFPE tissue is more problematic, requiring
an area of at least 20mm2 to achieve acceptable, but not
exceptional, performance.
Evaluation of PCR bias
PCR ampliﬁcation of small amounts of bisulﬁte-treated
DNA can result in PCR bias and inaccurate DNA methy-
lation calling (47). In DNA samples obtained from
females, the X chromosome serves as a good internal
Figure 2. LCM-RRBS is reproducible and robust across 1 ng extracted from bulk fresh frozen and FFPE samples. CGI methylation (top panels) and
the methylation at 2-kb regions ﬂanking the TSS (bottom panels) were compared between (A) 1 ng (LCM-RRBS) and 400 ng of puriﬁed leukocyte
genomic DNA (RRBS), and (B) 1 ng of FFPE DNA and 1ng of fresh frozen genomic DNA extracted from the same endometrial tumor
(LCM-RRBS).
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control for assessing PCR bias, as X inactivation methy-
lates one copy of the X chromosome at most loci. To
determine whether LCM-RRBS suffers from PCR bias,
we analyzed the fraction of molecules that were
methylated at loci known to be affected by X inactivation.
As expected, the majority (>70%) of CGIs on the X
chromosome showed an intermediate level (30–70%) of
DNA methylation across all fresh frozen samples and
the 20-mm2 FFPE sample (Supplementary Figure S6),
demonstrating that LCM-RRBS shows little PCR bias.
We conclude that LCM-RRBS shows little PCR bias
across 2mm2 of fresh frozen tissue and 20mm2 of FFPE
tissue.
Analysis of GDX-induced adrenocortical neoplasia in the
mouse using LCM-RRBS
To demonstrate the utility of LCM-RRBS in a biological
setting, we applied the method to analyze the DNA
methylation of neoplasms that arise in the adrenal
cortex of DBA/2J mice after GDX. Although genetic
factors have been identiﬁed that inﬂuence susceptibility
to GDX (36,37), little is known about the role DNA
methylation plays in the formation of GDX-induced neo-
plasia. Molecular characterization is further complicated
because mouse adrenal glands are only 0.1 cm2 in size and
neoplasms arise among normal tissues, requiring LCM
enrichment methods for tissue isolation. We therefore
applied LCM-RRBS to neoplastic and adjacent normal
mouse adrenal tissues (Figure 4).
In one multiplexed experiment, we interrogated the
methylation status of >13 000 promoters and >13 000
CGIs of six tissue samples (three neoplastic and three
normal representing three different mice), across an
average of >800 000 CpGs per sample (Figure 4 and
Supplementary Table S1). Using a threshold difference
of at least 10%, 37 promoters were signiﬁcantly
hypomethylated and 8 promoters were signiﬁcantly
hypermethylated (P< 0.05, FDR adjusted; Table 1 and
Supplementary Table S2) in the neoplasms compared
with adjacent normal tissue. Many of the top hypo- and
hypermethylated genes have been implicated in cell fate de-
termination and differentiation, including adrenocortical
formation (Tinagl1), gonad development (Foxs1, Wdr63,
Tmem184a), pancreas development (Nsmce1), kidney de-
velopment (Hoxc10, Dpep1), prostate development
(Il17rc, Ano7) and muscle and skeletal development
(Myo18b, Trim63, Lmod3, Meox1). The observed methy-
lation changes suggest the neoplastic tissue may arise
owing to aberrant gene expression of genes normally
silent in adrenocortical cells or the silencing of adrenal-
speciﬁc markers. To validate our ﬁndings, we performed
bisulﬁte-speciﬁc PCR (BSP) followed by sequencing of
three hypomethylated promoters and one
hypermethylated promoter on neoplastic and normal
tissues isolated by LCM. For all promoters tested, BSP
showed a signiﬁcant difference (Fisher’s exact test,
P< 1015) in DNA methylation between the neoplasia
and normal tissue as predicted by LCM-RRBS
(Figure 5). Taken together, these results demonstrate
that LCM-RRBS can identify differentially methylated
genes in a complex tissue and reveal functionally
relevant epigenetic effects.
DISCUSSION
Current DNA methylation mapping techniques are
limited by input and the number of loci interrogated.
RRBS, a genome-wide DNA methylation mapping
Figure 3. LCM-RRBS is robust across microdissected samples collected from fresh frozen and FFPE tissues. Fresh frozen and FFPE mouse liver
was collected for DNA methylation proﬁling. LCM was used to collect tissue from areas ranging in size from 20 to 2 mm2. CGI methylation (top
panels) and methylation at 2-kb regions ﬂanking the TSS (bottom panels) were compared between (A) fresh frozen samples (LCM-RRBS) and 400 ng
of puriﬁed mouse liver genomic DNA (RRBS), and (B) FFPE samples (LCM-RRBS) and 400 ng of puriﬁed mouse liver genomic DNA (RRBS).
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Table 1. Top hypermethylated and hypomethylated genes in GDX-induced adrenocortical neoplasms of the mouse
Gene symbol Entrez gene name Functiona Percent methylationb P valuec
Normal Neoplasia Difference
Tinagl1 Tubulointerstitial nephritis antigen-
like 1
Zonal differentiation of
adrenocortical cells
18 64 46 0.0235
Dennd4b DENN/MADD domain containing
4B
unknown 34 62 29 0.0125
L1td1 LINE-1 type transposase domain
containing 1
Embryonic stem cell renewal and
identity
33 59 27 0.0241
Syne4 Spectrin repeat containing, nuclear
envelope family member 4
Microtubule-dependent nuclear
positioning
45 70 25 0.0189
Fignl2 Fidgetin-like 2 Unknown 40 63 23 0.0125
Slc5a5 Solute carrier family 5 (sodium
iodide symporter), member 5
Regulates iodine uptake in the
thyroid
33 51 18 0.0352
Nsmce1 Non-SMC element 1 homolog Pancreas development 67 81 14 0.0320
Hoxc10 Homeobox C10 Kidney development and limb
formation
42 54 12 0.0125
Myo18b Myosin XVIIIb Myoﬁbrillar structure
maintenance
86 34 52 0.0230
B3gnt8 UDP-GlcNAc:betaGal beta-1,3-N-
acetylglucosaminyltransferase 8
Positive regulator of cell
proliferation
72 32 40 0.0125
P2rx7 Purinergic receptor P2X, ligand-
gated ion channel, 7
Neuronal differentiation and
migration
79 46 33 0.0244
Dpep1 Dipeptidase 1 (renal) Kidney and genitourinary
development
80 49 31 0.0027
Foxs1 Forkhead box S1 Neuronal differentiation and tes-
ticular development
95 64 31 0.0027
Angptl2 Angiopoietin-like 2 Mediates differentiation, migra-
tion and inﬂammation
84 54 30 0.0125
Igfbp6 Insulin-like growth factor binding
protein 6
Igf2 signaling 76 46 30 0.0406
Nt5dc2 50-nucleotidase domain containing 2 Unknown 85 57 28 0.0224
Trim63 Tripartite motif-containing 63 Cardiomyocyte development 69 41 28 0.0352
Ica RIKEN cDNA 1300017J02 gene Putative hepatic iron regulator 86 59 27 0.0125
Wdr63 WD repeat domain 63 Gonad development 85 59 27 0.0128
aGene function from NCBI, GeneRIF.
bMean methylation of three mice.
cFDR corrected.
Figure 4. DNA methylation proﬁling of GDX-induced adrenocortical neoplasms and adjacent normal tissue using LCM-RRBS. The adrenal glands
of three ovariectomized DBA/2J mice were fresh frozen in Tissue-tek O.C.T. compound, cryosectioned and stained. Shown are representative
cryosections pre- and post-LCM. Normal cells in the zona fasciculata contain large lipid droplets that are easily recognized. In contrast, neoplastic
cells distort the normal adrenal zonal architecture and contain relatively few lipid droplets. The microdissected normal tissue included zona
glomerulosa and zona fasciculata cells; care was taken to avoid dissection of X-zone (X), medulla (M) or capsule cells, as these cell types have
distinct developmental origins (48), and therefore may have different epigenetic ﬁngerprints. An average of 5.5 mm2 of neoplastic (red) and normal
(green) tissue per adrenal pair was collected and analyzed using LCM-RRBS.
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technique, was recently shown to function on 0.5–10 ng of
genomic DNA isolated from mouse embryos (34). RRBS,
however, has not been demonstrated to function on LCM
samples collected from FFPE tissue nor is it amenable to
large scale sample processing. We have developed a new
method, LCM-RRBS, which can accurately proﬁle
genome-wide DNA methylation of many LCM samples
in parallel at single base pair resolution.
Our method can be implemented in 3–4 days, and the
bulk of the protocol can be automated for high-through-
put 96-well experiments. While traditional RRBS requires
each processed sample to undergo gel extraction, a labori-
ous process when processing more than a few samples, our
method pools all samples together before gel extraction,
reducing the required number of gel extractions to one.
Thus, a large number of samples can be easily processed at
a single time. Furthermore, because high DNA loss results
from gel extraction, pooling samples before gel extraction
allows the use of low (1 ng) DNA inputs.
The LCM-RRBS protocol affords a signiﬁcant reduc-
tion in sequencing costs compared with whole-genome
bisulﬁte sequencing. We typically collect 1.5 gigabases
(GB) per sample, which is considerably less than the
60GB needed for 20 coverage of a whole-genome
bisulﬁte library. The sequencing cost per sample can be
reduced further if fewer CpGs are interrogated. For
example, if a smaller size fraction is isolated during gel
extraction, only 0.75GB is required per sample.
We found that although formalin ﬁxation and parafﬁn
embedding does not alter DNA methylation per se, at
least 20mm2 of tissue must be isolated for accurate
DNA methylation proﬁling. We were able to create
LCM-RRBS libraries from 10, 5 and 2mm2 of FFPE
tissue and obtained similar numbers of sequencing
Figure 5. Validation of differentially methylated promoters. The DNA methylation of one hypermethylated and three hypomethylated promoters
was interrogated by BSP and sequencing across enriched neoplastic and normal samples. All genes show a statistically signiﬁcant difference (Fisher’s
exact test, P< 1015) in DNA methylation using BSP. Each colored box represents an individual CpG dinucleotide within a 2-kb region centered
around the TSS. High (yellow), moderate (black), low (blue) and undetermined methylation levels are shown for each CpG. The mean methylation of
each region interrogated is shown to the right of each heatmap. The red box indicates the region of the promoter that was interrogated by
LCM-RRBS and BSP.
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reads as with fresh frozen samples, but overall mapping
quality was very low (30% aligned) in the FFPE
samples, precluding an accurate analysis of DNA methy-
lation. In contrast, LCM-RRBS generated high-quality
methylation maps from 2 mm2 of microdissected fresh
frozen tissue, as demonstrated by our analysis of
mouse liver.
To demonstrate the utility of LCM-RRBS, we analyzed
the DNA methylation patterns of GDX-induced
adrenocortical neoplasms using an average of 5.5mm2 of
fresh frozen tissue. We hypothesized that aberrant DNA
methylation changes could be involved in the formation of
these neoplastic tissues. Indeed, recent studies have shown
that altered DNA methylation can redirect cell fate in
endocrine tissues (49). Conditional mutagenesis of the
mouse Dnmt1 gene, which encodes the maintenance
DNA methyltransferase, converts insulin-producing pan-
creatic b-cells into glucagon-producing a-cells (49). It is
thought that because of a common developmental
origin, b- and a-cells share general epigenetic programs
that provide a compatible environment for cell fate con-
versions (50). GDX-induced adrenocortical neoplasia may
be another example of DNA methylation–regulated cell
fate conversion in an endocrine tissue; in this case,
adrenocorticoid-producing cells become sex steroid–
producing cells (39,51,52). The changes in DNA methyla-
tion we observe around the TSS could lead to changes in
gene expression (53,54). Several of the genes we found to
be differentially methylated in GDX-induced
adrenocortical neoplasms have established roles in
adrenocortical or gonadal development. For example,
Tinagl1, a gene implicated in adrenal zonation (55,56),
showed a gain in DNA methylation, which could lead to
down-regulation. Wdr63, Foxs1 and Tmem184a, genes
involved in gonadal development (57–60), showed a loss
of DNA methylation, which could lead to the aberrant
expression of these gonadal-like markers in the adrenal
cortex. Furthermore, Srd5a3, a gene involved in the bio-
synthesis of the potent androgen 5a-dihydrotestosterone
(61), showed a loss of DNA methylation, which could
enhance the ectopic production of sex steroids in the
adrenal gland (62). Future studies will explore the role
of these methylation changes in the pathogenesis of
GDX-induced adrenocortical neoplasia.
In conclusion, LCM-RRBS is a robust cost-effective
method for the DNA methylation analysis of heteroge-
neous tissues. This technique allows the study of tumor
evolution and epigenetic heterogeneity in situ of <1 ng
(150 cells) and can also be applied to investigate the
role of DNA methylation in cell fate speciﬁcation during
tissue development. LCM-RRBS is an important mile-
stone toward highly parallel in situ analysis of single
cells. We anticipate that this protocol will greatly facilitate
the analysis of any sample that contains multiple cell
types.
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